Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases (Q27853213)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gilbert Massard

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Stéphane Renaud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Pierre-Emmanuel Falcoz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Mickaël Schaëffer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Benoit Romain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Anne Olland

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jérémie Reeb

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Nicola Santelmo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Marie-Pierre Chenard

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Michèle Legrain

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Anne-Claire Voegeli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Michèle Beau-Faller

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

2 June 2020

language of work or name

English

0 references

publication date

20 October 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1206-1215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

2 June 2020

copyright license

start time

15 September 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

20 March 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Recurrence after surgery in patients with NSCLC.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute pl

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4647870

Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib.

29 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2015.327

Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2015.327

The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2015.327

Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2015.327

[Practical issues in the surgical treatment of non-small cell lung cancer. Recommendations from the French Society of Thoracic and Cardiovascular Surgery]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26372703

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26372703

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2015.327

2 references

Consolidated OpenCitations Corpus – April 2017

2181378

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 June 2020

1019887568

0 references

2181378

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

13 November 2016

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26372703%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

2 references

Consolidated OpenCitations Corpus – April 2017

2181378